Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Oct 17;28(1):174–182. doi: 10.1158/1055-9965.EPI-18-0483

Table 1.

Analytical performance of the 6-plex immunoassay.

Mean (pg/mL) Intra-assay Precision (%CV) Inter-assay Precision (%CV) Intra-assay Precision (%CV) Inter-assay Precision (%CV) LOB (pg/mL) LLOQ (pg/mL) ULOQ (pg/mL) 6-plex vs Monoplex, Pearson R/p value 6-plex vs ELISA, Pearson R/p value
QC1 QC2 QC1 QC2 QC1 QC2 Pooled Normal Serum Pooled Normal Se rum
OPN 13448.3 1228.3 2.1 5.1 3.7 4.2 12.9 13.7 19.9 157.3 37174.3 0.9987/0.0013 0.8945/0.0066
MIA 481.7 48.3 8.6 10.0 4.4 8.4 10.2 13.7 0.1 6.7 1550.0 0.9888/0.0112 ND*
CEACAM-1 6141.7 658.3 9.3 6.6 8.6 16.3 16.5 19.3 19.8 96.0 20042.7 0.9715/0.0285 ND
MIC-1 963.3 93.3 8.1 10.3 21.5 18.8 14.1 17.4 0.1 12.0 2383.7 0.9996/0.0004 ND
SPON1 4746.7 473.3 4.3 2.7 5.0 6.8 14.8 16.8 12.5 60.3 15124.7 0.9675/0.0325 ND
HSP27 933.3 88.3 15.4 12.6 14.5 13.2 19.6 29.3 0.5 12.0 3078.0 0.9997/0.0003 0.9254/<0.00001

NOTE: QC1, high control. QC2, low control. LOB, limit of blank. LLOQ, lower limit of quantitation. ULOQ, upper limit of quantification.

The correlation of 6-plex vs monoplex was examed on 4 doses of individual recombinant proteins. The correlation of 6-plex vs the

commercial ELISA kit was examed on 7 (OPN) or 13 (HSP27) patient sera.

*

, ND, not determined.